NCT04623814 is a Phase 1 clinical trial of Food in Major Depressive Disorder, sponsored by Sunshine Lake Pharma Co., Ltd..

Who is sponsoring NCT04623814?

NCT04623814 is sponsored by Sunshine Lake Pharma Co., Ltd..

What drugs are being tested in NCT04623814?

Interventions in NCT04623814: Food, HEC113995, placebo.

What condition does NCT04623814 study?

NCT04623814 studies Major Depressive Disorder.

Is NCT04623814 still recruiting?

NCT04623814 is currently completed. Last updated 25 November 2020.

Last reviewed 2020-11-25 · How we verify

NCT04623814

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

the Safety, Tolerability, and Pharmacokinetics Study of HEC113995

Completed Phase 1 Last updated 25 November 2020

What this trial tests

Phase 1 trial testing Food in Major Depressive Disorder in 58 participants. Completed in 12 August 2020.

Timeline

30 March 2020

Primary endpoint
12 August 2020

12 August 2020

Quick facts

Lead sponsor	Sunshine Lake Pharma Co., Ltd.
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	double
Primary purpose	treatment
Enrollment	58
Start date	30 March 2020
Primary completion	12 August 2020
Estimated completion	12 August 2020
Sites	1 location across China

Drugs / interventions tested

Food
HEC113995 — full drug profile →
placebo

Conditions studied

Major Depressive Disorder — all drugs for Major Depressive Disorder →

Sponsor

Sunshine Lake Pharma Co., Ltd. — full company profile →

Who can join

Adults 18 to 45, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC113995 PA•H2O in Healthy Subjects

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Food

Trials testing the same drug.

NCT06568497 — Dairy and Vegan Cheese: Effect on Satiety and Blood Glucose · NA · recruiting
NCT06378658 — A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Heal · Phase 1 · completed
NCT06333184 — Smoothies and Blood Sugars · NA · completed
NCT05521711 — TRADE Trial - Tree Nut Immunotherapy Route Development and Evaluation · NA · recruiting
NCT05870891 — Equivalent Glycemic Load and Insulinemic Response Elicited by 7 Low Carbohydrate Products in Healthy Adults · NA · completed

Other recruiting trials for Major Depressive Disorder

Currently open trials in the same condition.

NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT06749392 — An Individual-specific Synchrony Signature · NA · recruiting
NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
NCT07242105 — Optimizing Brain Excitability in Depression · NA · recruiting

Other Sunshine Lake Pharma Co., Ltd. trials

Trials by the same sponsor.

NCT07341672 — A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itrac · Phase 1 · not yet recruiting
NCT05048368 — Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function · Phase 1 · not yet recruiting
NCT07376200 — Single-ascending Dose Study of HEC-151 Injection · Phase 1 · not yet recruiting
NCT07082842 — Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF · Phase 3 · not yet recruiting
NCT07211165 — Clinical Study on the Mass Balance of Clifutinib · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04623814 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sunshine Lake Pharma Co., Ltd.
Last refreshed: 25 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04623814.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing